Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Lowe DE, Ernst SM, Zito C, Ya J, Glomski IJ.

Infect Immun. 2013 Dec;81(12):4408-20. doi: 10.1128/IAI.00484-13. Epub 2013 Sep 16.

2.

Dissemination bottleneck in a murine model of inhalational anthrax.

Plaut RD, Kelly VK, Lee GM, Stibitz S, Merkel TJ.

Infect Immun. 2012 Sep;80(9):3189-93. doi: 10.1128/IAI.00515-12. Epub 2012 Jul 2.

3.

Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.

Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL.

PLoS Pathog. 2007 Jun;3(6):e76.

4.

Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting.

Glomski IJ, Dumetz F, Jouvion G, Huerre MR, Mock M, Goossens PL.

Microbes Infect. 2008 Oct;10(12-13):1398-404. doi: 10.1016/j.micinf.2008.07.042. Epub 2008 Aug 13.

PMID:
18762267
5.
6.

Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells.

Shetron-Rama LM, Herring-Palmer AC, Huffnagle GB, Hanna P.

Microb Pathog. 2010 Jul-Aug;49(1-2):38-46. doi: 10.1016/j.micpath.2010.02.004. Epub 2010 Feb 25.

PMID:
20188814
7.

Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host.

Weiner ZP, Glomski IJ.

Infect Immun. 2012 May;80(5):1626-33. doi: 10.1128/IAI.06061-11. Epub 2012 Feb 21. Review.

8.

Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax.

Gold JA, Hoshino Y, Jones MB, Hoshino S, Nolan A, Weiden MD.

PLoS One. 2007 Aug 15;2(8):e736.

9.

Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.

Crawford MA, Burdick MD, Glomski IJ, Boyer AE, Barr JR, Mehrad B, Strieter RM, Hughes MA.

PLoS Pathog. 2010 Nov 18;6(11):e1001199. doi: 10.1371/journal.ppat.1001199.

10.

Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.

Gutting BW, Nichols TL, Channel SR, Gearhart JM, Andrews GA, Berger AE, Mackie RS, Watson BJ, Taft SC, Overheim KA, Sherwood RL.

Front Cell Infect Microbiol. 2012 Jun 28;2:87. doi: 10.3389/fcimb.2012.00087. eCollection 2012.

11.

Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.

Lyons CR, Lovchik J, Hutt J, Lipscomb MF, Wang E, Heninger S, Berliba L, Garrison K.

Infect Immun. 2004 Aug;72(8):4801-9.

12.

Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route.

Cleret A, Quesnel-Hellmann A, Vallon-Eberhard A, Verrier B, Jung S, Vidal D, Mathieu J, Tournier JN.

J Immunol. 2007 Jun 15;178(12):7994-8001.

13.

In trans complementation of lethal factor reveal roles in colonization and dissemination in a murine mouse model.

Lowe DE, Ya J, Glomski IJ.

PLoS One. 2014 Apr 24;9(4):e95950. doi: 10.1371/journal.pone.0095950. eCollection 2014.

14.

Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.

Cote CK, Bozue J, Twenhafel N, Welkos SL.

J Med Microbiol. 2009 Jun;58(Pt 6):816-25. doi: 10.1099/jmm.0.008656-0.

PMID:
19429760
15.

Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax.

Thomas R, Davies C, Nunez A, Hibbs S, Flick-Smith H, Eastaugh L, Smither S, Gates A, Oyston P, Atkins T, Eley S.

J Med Microbiol. 2010 Dec;59(Pt 12):1415-27. doi: 10.1099/jmm.0.024117-0. Epub 2010 Aug 26.

PMID:
20798216
16.

Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Crawford MA, Zhu Y, Green CS, Burdick MD, Sanz P, Alem F, O'Brien AD, Mehrad B, Strieter RM, Hughes MA.

Infect Immun. 2009 Apr;77(4):1664-78. doi: 10.1128/IAI.01208-08. Epub 2009 Jan 29.

17.

In vivo germination of Bacillus anthracis spores during murine cutaneous infection.

Corre JP, Piris-Gimenez A, Moya-Nilges M, Jouvion G, Fouet A, Glomski IJ, Mock M, Sirard JC, Goossens PL.

J Infect Dis. 2013 Feb 1;207(3):450-7. doi: 10.1093/infdis/jis686. Epub 2012 Nov 12.

18.

Quantitative pathology of inhalational anthrax I: quantitative microscopic findings.

Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH.

Mod Pathol. 2001 May;14(5):482-95.

19.

Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.

Wilson MK, Vergis JM, Alem F, Palmer JR, Keane-Myers AM, Brahmbhatt TN, Ventura CL, O'Brien AD.

Infect Immun. 2011 Aug;79(8):3012-9. doi: 10.1128/IAI.00205-11. Epub 2011 May 16.

20.

Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax.

Garraud K, Cleret A, Mathieu J, Fiole D, Gauthier Y, Quesnel-Hellmann A, Tournier JN.

Infect Immun. 2012 Jan;80(1):131-42. doi: 10.1128/IAI.05988-11. Epub 2011 Oct 24.

Items per page

Supplemental Content

Write to the Help Desk